Optional Lab Testing Helps uncover metabolic or hormonal drivers
Furthermore, GHK-Cu may reduce the appearance of lesions and acne scars
[1] Additionally, the label cautions that tirzepatide may reduce the exposure of oral contraceptives taken concomitantly, particularly after initiation and dose escalation, potentially requiring alternative contraceptive methods
The effects of this presentation on weight and glycemia in clinical trials and real-world settings are comparable to those induced by the subcutaneous presentation, although a specific indication for weight control without DT2 is still lacking.86 In order to avoid confusion in daily clinical practice, it is important to note that liraglutide 3mg and semaglutide 2.4mg can be used in patients with DT2, provided these are obese or overweight with comorbidities
Accessed 08 Mar 2018
Choi JH, Cho SH, Kim SN, Suh JD, Cho JH